MEKINIST

trametinib · Novartis Pharmaceuticals Corporation

Drug timelines are a Plus or Pro feature.

80 regulatory and trial events tracked for MEKINIST, covering 2013-05-29 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: 24VA021; VATCH Trametinib for Ras/MAPK Pathway VAs [Phase 2]